Back to Search
ANYA RING, DO
DO
Pediatrics Physician
NPI: 1902391782IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospice and Palliative Medicine (Internal Medicine) Physician
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
81298(WI)
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
81298(WI)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Additional
HOSPICE/PALLIATIVE CARE
Education
OTHER
Class of 2018
Research & Publications (20)
[Pneumopericardium after hyperemesis. Possible result of the Macklin effect].
PMID 19255734·Chirurg·2010
5-case
The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
PMID 17466700·Am J Obstet Gynecol·2007
4-observational
Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications.
PMID 12756077·Clin Breast Cancer·2003
6-review
Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.
PMID 10888310·Pharm Res·2000
8-other
Randomized trial of reattribution on psychosocial talk between doctors and patients with medically unexplained symptoms.
PMID 19573262·Psychol Med·2010
2-rct
Antidepressants, social adversity and outcome of depression in general practice.
PMID 19589602·J Affect Disord·2010
8-other
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
PMID 19401066·Health Technol Assess·2009
2-rct
Neuronal glucose but not lactate utilization is positively correlated with NMDA-induced neurotransmission and fluctuations in cytosolic Ca2+ levels.
PMID 19393013·J Neurochem·2009
7-preclinical
Primary care consultations about medically unexplained symptoms: how do patients indicate what they want?
PMID 19165548·J Gen Intern Med·2009
8-other
Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.
PMID 19476474·Diabetes Obes Metab·2009
4-observational
Isolation and characterization of adult human liver progenitors from ischemic liver tissue derived from therapeutic hepatectomies.
PMID 19108677·Tissue Eng Part A·2009
7-preclinical
Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.
PMID 19552619·Curr Med Res Opin·2009
2-rct
In vivo analysis of tissue response to plasma-treated collagen-I-coated titanium alloys.
PMID 19628943·Eur Surg Res·2009
7-preclinical
Cognitive dysfunction after experimental febrile seizures.
PMID 19000675·Exp Neurol·2009
7-preclinical
Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
PMID 19240212·Proc Natl Acad Sci U S A·2009
7-preclinical
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers.
PMID 18812608·J Clin Pharmacol·2008
3-trial
In vivo microvascular response of murine cutaneous muscle to ibuprofen-releasing polyurethane foam.
PMID 18593395·Int Wound J·2008
7-preclinical
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.
PMID 18824608·Antimicrob Agents Chemother·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1000 OAKLAND DR
KALAMAZOO, MI 49008 - Phone
- (269) 337-6345
Quick Facts
- NPI
- 1902391782
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile